Stock MXCT MAXCYTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications MaxCyte, Inc.

Equities

MXCT

US57777K1060

Market Closed - London S.E.
Other stock markets
 16:35:03 29/04/2024 BST 		5-day change 1st Jan Change
295 GBX 0.00% Intraday chart for MaxCyte, Inc. -5.75% -16.31%
04-02 MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines CI
03-13 BTIG Adjusts Price Target on MaxCyte to $8 From $10, Maintains Buy Rating MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. MXCT Stock
  4. News MaxCyte, Inc.
  5. Official Publications